Skip to main content

Table 1 Baseline characteristics of the study population

From: Single-plane versus real-time biplane approaches for ultrasound-guided central venous catheterization in critical care patients: a randomized controlled trial

Characteristics

Single-plane (n = 128)

x-Plane (n = 128)

P

Age (years)

69 (52–84 [13–104])

74 (58–86 [18–99])

0.128

Sex

 Male

79 (61.7%)

84 (65.6%)

0.516

 Female

49 (38.3%)

44 (34.4%)

 

Height (cm)

167 (161–171 [130–183])

168 (160–173 [140–186])

0.999

Body weight (kg)

64 (55–78 [34–120])

63 (55–75 [40–120])

0.625

BMI (kg/m2)

23.4 (20.6–27.0 [14.8–38.3])

22.7 (20.4–25.8 [16.0–36.5])

0.420

Temperature (°C)

36.5 (36.3–36.7 [35.8–38.8])

36.5 (36.4–36.7 [35.9–38.9])

0.113

Pulse (bpm)

83 (76–98 [58–133])

86 (75–104 [55–162])

0.388

Respiration (bpm)

18 (18–19 [13–27])

18 (18–19 [12–30])

0.957

Systolic pressure (mmHg)

124 (106–138 [63–187])

124 (114–142 [75–191])

0.217

Diastolic pressure (mmHg)

72 (63–81 [31–110])

74 (66–80 [45–140])

0.455

TT (s)

16.5 (15.8–18.3 [13.6–96.8])

17.0 (16.0–19.0 [13.4–203.0])

0.184

APTT (s)

37.5 (33.1–43.3 [22.0–160.1])

38.6 (34.6–44.0 [24.9–163.3])

0.429

PT (s)

14.6 (13.7–16.2 [11.5–35.4])

15.1 (13.7–16.4 [10.8–116.8])

0.561

PTA (%)

78.0 (63.6–89.0 [20.0–121.0])

76.0 (65.0–86.0 [5.0–127.0])

0.584

INR

1.14 (1.05–1.30 [0.91–3.50])

1.17 (1.07–1.30 [0.89–16.09])

0.583

FIB (g/L)

3.83 (2.87–4.91 [1.26–8.03])

4.02 (2.88–5.77 [0.60–10.67])

0.116

D–Dimer (μg/ml)

2.58 (1.31–5.09 [0.14–20.00])

2.57 (1.18–4.77 [0.26–20.00])

0.889

Platelets (× 103/μL)

186 (130–244 [9–402])

181 (111–245 [9–500])

0.970

Reasons for catheterization (n)

 Infusion

102 (79.7%)

106 (82.8%)

0.522

 Dialysis

26 (20.3%)

22 (17.2%)

 

Cannulation site

 IJV

87 (68.0%)

95 (74.2%)

0.270

 FV

41 (32.0%)

33 (25.8%)

 

Side of catheterization (n)

 Left

15 (11.7%)

23 (18.0%)

0.160

 Right

113 (88.3%)

105 (82.0%)

 
  1. BMI Body mass index; TT Thrombin time; APTT Activated partial thromboplastin time; PT Prothrombin time; PTA Prothrombin activity; INR International normalized ratio; FIB Fibrinogen; IJV Internal jugular vein; FV Femoral vein